Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERCC5 | P28715 | 10/20 | 1.00 |
| ▸ | FEN1 | P39748 | 10/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 5/20 | 1.00 |
| ▸ | HAO1 | Q9UJM8 | 5/20 | 0.77 |
| ▸ | MEN1 | O00255 | 2/20 | 0.73 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.73 |
| ▸ | HPGD | P15428 | 2/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.73 |
| ▸ | MAPT | P10636 | 1/20 | 0.73 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.73 |
| ▸ | CES1 | P23141 | 1/20 | 0.73 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.73 |
| ▸ | PLOD2 | O00469 | 1/20 | 0.57 |
| ▸ | PLOD3 | O60568 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27655689 | 0.98 | ERCC5 (0.95) | ERCC5FEN1PTPN1HAO1MEN1 | |
| SCHEMBL27835156 | 0.98 | ERCC5 (0.95) | ERCC5FEN1PTPN1HAO1MEN1 | |
| SCHEMBL28005060 | 0.98 | ERCC5 (0.95) | ERCC5FEN1PTPN1HAO1MEN1 | |
| SCHEMBL27573155 | 0.98 | ERCC5 (0.95) | ERCC5FEN1PTPN1HAO1MEN1 | |
| SCHEMBL27742318 | 0.98 | ERCC5 (0.95) | ERCC5FEN1PTPN1HAO1MEN1 | |
| SCHEMBL30364011 | 0.98 | ERCC5 (0.95) | ERCC5FEN1PTPN1HAO1MEN1 | |
| SCHEMBL27691553 | 0.98 | ERCC5 (0.95) | ERCC5FEN1PTPN1HAO1MEN1 | |
| SCHEMBL27316384 | 0.98 | ERCC5 (0.95) | ERCC5FEN1PTPN1HAO1MEN1 | |
| SCHEMBL9648913 | 0.90 | ERCC5 (0.82) | ERCC5FEN1PTPN1HAO1MEN1 | |
| Dibenzoylmethane SCHEMBL29586365 | 0.87 | MEN1 (0.94) | ERCC5FEN1PTPN1HAO1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6599370-B2 | Stabilized alkaline compositions for cleaning microelectronic substrates | MALLINCKRODT INC. | 2003-07-29 | — | — | US | claimed |
| US-6585825-B1 | Metal ion free solution containing base, silicate, stabilizer and water; removing photoresist residues and other metallic and organic contaminates from semiconductor wafers without damaging | MALLINCKRODT INC | 2003-07-01 | — | — | US | claimed |
| WO-2000066588-A1 | DIRECT C-14 OXIDATION OF OPIOIDS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENTOF HEALTH A ND HUMAN SERVICES (US) | 2000-11-09 | — | — | WO | claimed |
| EP-0362012-B1 | Stabiliser compositions for halogenated polymers containing beta-diketone, hydrotalcite and dihydropyridine, and polymers stabilized therewith | ATOCHEM ELF SA (FR) | 1993-12-29 | — | — | EP | claimed |
| EP-0518908-A1 | METHOD FOR POLYMERIZATION OF EPOXIDE COMPOUNDS. | RUETGERSWERKE AG (DE) | 1992-12-23 | — | — | EP | claimed |
| WO-1991013925-A1 | METHOD FOR POLYMERIZATION OF EPOXIDE COMPOUNDS | RÜTGERSWERKE AKTIENGESELLSCHAFT (DE) | 1991-09-19 | — | — | WO | claimed |
| JP-5286890-A | — | — | None | — | — | JP | disclosed |
| US-20250213569-A1 | METHODS AND COMPOSITIONS FOR MEASURING AND INHIBITING EXONUCLEASE ACTIVITY | NEW YORK UNIVERSITY (US) | 2025-07-03 | — | — | US | disclosed |
| CN-117337276-B | Process for recycling ethylene in an ethylene oligomerization reactor system | 切弗朗菲利浦化学公司 | 2025-02-07 | — | — | CN | disclosed |
| CN-118974272-A | Label fragmenting workflow | 因美纳有限公司 | 2024-11-15 | — | — | CN | disclosed |
| EP-3022792-B1 | LOW TEMPERATURE SOLID OXIDE CELLS | FCET INC (US) | 2024-09-11 | — | — | EP | disclosed |
| CN-118574804-A | Heat exchange configuration for olefin oligomerization | 切弗朗菲利浦化学公司 | 2024-08-30 | — | — | CN | disclosed |
| US-12071697-B2 | Low temperature electrolytes for solid oxide cells having high ionic conductivity | FCET, INC. (US) | 2024-08-27 | — | — | US | disclosed |
| US-4369206-A | HARDENING COATING WITH AMINES | BAYER AKTIENGESELLSCHAFT (DE) | 1983-01-18 | — | — | US | disclosed |
| US-4315932-A | AND SULFANILAMIDES | BURROUGHS WELLCOME CO. (US) | 1982-02-16 | — | — | US | disclosed |
| US-4288365-A | 1H-PYRIMIDO(4,5-C)-1,2-DIAZEPINES | BURROUGHS WELLCOME CO. (US) | 1981-09-08 | — | — | US | disclosed |
| EP-0004079-B1 | SUPPORT CATALYST FOR THE PREPARATION OF VINYL ACETATE FROM ETHYLENE, ACETIC ACID AND OXYGEN IN THE GASEOUS PHASE. | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-06-17 | — | — | EP | disclosed |
| US-4260758-A | MICROBIOCIDES | BURROUGHS WELLCOME CO. (US) | 1981-04-07 | — | — | US | disclosed |
| US-4237289-A | MICROBIOCIDES | BURROUGHS WELLCOME CO. (US) | 1980-12-02 | — | — | US | disclosed |
| EP-0004079-A2 | Support catalyst for the preparation of vinyl acetate from ethylene, acetic acid and oxygen in the gaseous phase. | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-09-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250213569-A1 | METHODS AND COMPOSITIONS FOR MEASURING AND INHIBITING EXONUCLEASE ACTIVITY | DCLRE1B, RNASE1, ADAR | ERCC5 258/4885FEN1 10/4885PTPN1 1892/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.